Etravirine 69315-0285-20

Package NDC

69315-0285-20

Manufacturer: Leading Pharma, Llc
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: June 5, 2022
Listing Expires: December 31, 2026
Application: ANDA215402

Need to source Etravirine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Etravirine	100 mg/1

Drug Class

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 2C9 Inhibitors [MoA]

Selected Package

69315-0285-20Selected

120 TABLET in 1 BOTTLE (69315-285-20)